On 10 de nov. de 2025, OGN reported earnings of 1.01 USD per share (EPS) for Q3 25, beating the estimate of 0.94 USD, resulting in a 6.80% surprise. Revenue reached 1.60 bilhão, compared to an expected 1.59 bilhão, with a 0.71% difference. The market reacted with a +13.72% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 9 analistas forecast an EPS of 0.76 USD, with revenue projected to reach 1.56 bilhão USD, implying an diminuir of -24.75% EPS, and diminuir of -2.86% in Revenue from the last quarter.
FAQ
What were Organon & Co.'s earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Organon & Co. reported EPS of $1.01, beating estimates by 6.8%, and revenue of $1.60B, 0.71% above expectations.
How did the market react to Organon & Co.'s Q3 2025 earnings?
The stock price moved up 13.72%, changed from $6.78 before the earnings release to $7.71 the day after.
When is Organon & Co. expected to report next?
The next earning report is scheduled for 11 de fev. de 2026.
What are the forecasts for Organon & Co.'s next earnings report?
Based on 9
analistas, Organon & Co. is expected to report EPS of $0.76 and revenue of $1.56B for Q4 2025.